HealthQuill Articles by: HealthQuill
Jubilant Ingrevia, an Indian public-listed company, has commissioned its new global-scale acetic anhydride plant at its facility in western India’s Bharuch.
Drugs Medical Pharma

Jubilant Ingrevia raises capacity of acetic anhydride plant

HQ Team April 18, 2023: Jubilant Ingrevia, an Indian public-listed company, has commissioned its new global-scale acetic anhydride plant at its facility in

Read More
Researchers at the Harvard Medical School and Taiwan’s National Change Kung University have invented a new artificial intelligence tool to accurately predict survival rates during and after colorectal cancer.
Drugs Medical Pharma

Free AI tools can predict how long a patient can survive colorectal cancer

HQ Team April 17, 2023: Researchers at the Harvard Medical School and Taiwan’s National Change Kung University have invented a new artificial intelligence

Read More
Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member nations during the two-day meeting starting in India today.
Drugs Health Pharma

Prevention, preparedness, response to top G20 health group agenda

HQ Team April 17, 2023: Health emergencies, prevention, preparedness, and response, will top the agenda at the second Health Working Group meeting of G20 member

Read More
US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.
Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from

Read More
Women farmers’ inequalities on the rise as global hunger intensifies
Climate Health Medical

Women farmers’ inequalities on the rise as global hunger intensifies

HQ Team April 14, 2023: Women, who account for one-third of those employed in the agricultural sector, are paid about 20% less than

Read More
SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk and immunocompromised patients.
Drugs Medical Pharma

SAB gets FDA fast track nod for experimental drug to treat influenza

HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk

Read More
New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose, the FDA stated.
Drugs Health Medical Pharma

USFDA updates safety warnings for opioid treatment drugs 

HQ Team April 14, 2023: New safety warnings will be required on prescription labels for opioid pain relievers to prevent addiction and overdose,

Read More
Alphabet Inc, Google's parent company, has signed two new power purchase agreements in Belgium and the Netherlands to meet its net-zero emissions by 2030.
Climate Health Medical

Alphabet signs pacts in Belgium, Netherlands for clean energy

HQ Team April 13, 2023: Alphabet Inc, Google’s parent company, has signed two new power purchase agreements in Belgium and the Netherlands to

Read More
Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid tumors.
Drugs Health Pharma

Canada’s Fusion gets FDA nod for drug tests to treat solid tumors

HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid

Read More
Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its relapsing multiple sclerosis drug after it caused liver injuries.
Drugs Health Pharma

FDA applies brakes on Merck’s multiple sclerosis drug tests

HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its

Read More